Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Helping PCOS patients focus on hope and control can reduce depression.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

The study identified key immune cell differences between mild and severe alopecia areata.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

The dog died from myxedema coma linked to severe atherosclerosis and thyroid issues.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Digital health education may reduce stress, anxiety, and depression in PCOS patients.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.